|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-0239-09
|
6505-01-391-6108
|
Graniestron Hydrochloride Inject |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00378-6989-62
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC49502-0685-26
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Mylan Specialty L.p.
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00487-9801-25
|
6505-01-391-6109
|
Ipratropium Bromide Inhalation S |
Nephron Pharmaceuticals Corporation
|
|
Quote
|
|
CATAFLAM
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
NDC00028-0151-01
|
6505-01-391-6112
|
Diclofenac Potassium Tablets |
Ciba
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
6505NCM116853
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Medical Standardization
|
|
Quote
|
|
27361
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Defense Logistics Agency
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC000338-1075-02
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
|
2B0792
|
6505-01-391-7023
|
Dobutamine Hydrochloride Injecti |
Baxter Healthcare Corporation
|
|
Quote
|
|
AFTER BITE
|
6505-01-392-6764
|
Ammonium Hydroxide Topical Solut |
Tender Corporation
|
|
Quote
|
|
06-1012
|
6505-01-392-6764
|
Ammonium Hydroxide Topical Solut |
Tender Corporation
|
|
Quote
|
|
NDC00536-1402-12
|
6505-01-392-8436
|
Hemorrhoidal Suppositories |
Rugby Group Inc
|
|
Quote
|
|
MYCELEX 7
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC16500-0250-20
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC16500-0250-20
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
2508
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00472-0220-41
|
6505-01-393-0433
|
Usp Clotrimazole Vaginal Cream |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
200 PROOF GALLON
|
6505-01-393-1640
|
Usp Alcohol |
Aaper Alcohol and Chemical Company
|
|
Quote
|
|
NDC00037-5020-01
|
6505-01-393-2134
|
Torsemide Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00054-0077-25
|
6505-01-393-2134
|
Torsemide Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00603-6134-21
|
6505-01-393-2135
|
Torsemide Tablets |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC00004-0262-49
|
6505-01-393-2136
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC53169-0102-60
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX TABLETS
|
6505-01-393-2136
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
NDC00004-0263-49
|
6505-01-393-2137
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC53169-0103-60
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
DEMADEX TABLETS
|
6505-01-393-2137
|
Torsemide Tablets |
Roche Diagnostics Corporation
|
|
Quote
|
|
NDC00037-5001-01
|
6505-01-393-2138
|
Torsemide Tablets |
Meda Pharmaceuticals, Inc
|
|
Quote
|
|
NDC00004-0265-49
|
6505-01-393-2139
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0264-49
|
6505-01-393-2140
|
Torsemide Tablets |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
94-6100
|
6505-01-393-2140
|
Torsemide Tablets |
Defense Medical Standardization
|
|
Quote
|
|
ZEMURON
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC63323-0426-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Elkins Telecommunications Llc
|
|
Quote
|
|
NDC00052-0450-15
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC00409-9558-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Hospira, Inc.
|
|
Quote
|
|
659850.4
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
ESMERON 10MG/ML 10VIALES
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
8470006598504
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Schering Plough, Sa
|
|
Quote
|
|
NDC00052-0450-15
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
ZEMURON
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
ZEMURON INJECTION
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Organon Inc
|
|
Quote
|
|
NDC63323-0426-05
|
6505-01-393-2144
|
Rocuronium Bromide Injection |
Fresenius Kabi Usa Llc
|
|
Quote
|
|
NDC00004-0267-06
|
6505-01-393-2148
|
Torsemide Injection |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00247-0261-30
|
6505-01-393-5858
|
Loracarbef Capsules |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
LORABID
|
6505-01-393-5858
|
Loracarbef Capsules |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
LORABID CAPSULES
|
6505-01-393-5858
|
Loracarbef Capsules |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00004-0268-06
|
6505-01-393-5860
|
Torsemide Injection |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
DILACOR XR
|
6505-01-393-7319
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
DILACOR XR CAPSULES
|
6505-01-393-7319
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00075-0251-99
|
6505-01-393-7319
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
DILACOR XR
|
6505-01-393-7437
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
DILACOR XR CAPSULES
|
6505-01-393-7437
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00075-0252-99
|
6505-01-393-7437
|
Diltiazem Extended-release Capsu |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC52544-0664-10
|
6505-01-393-7437
|
Diltiazem Extended-release Capsu |
Watson Labs Inc
|
|
Quote
|
|
MIRACLE GLOVE
|
6505-01-393-7718
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
94-6107
|
6505-01-393-7718
|
Glove Skin Protective Cream |
Defense Logistics Agency
|
|
Quote
|
|
40003
|
6505-01-393-7718
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
NDC08372-0720-32
|
6505-01-393-7718
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
MIRACLE GLOVE
|
6505-01-393-7720
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
40002
|
6505-01-393-7720
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
NDC08372-0720-08
|
6505-01-393-7720
|
Glove Skin Protective Cream |
Advanced Chemical Technology Inc
|
|
Quote
|
|
NDC58177-0006-04
|
6505-01-393-7950
|
Nitroglycerin Extended-release C |
Ethex Corp
|
|
Quote
|
|
NDC00904-0647-60
|
6505-01-393-7950
|
Nitroglycerin Extended-release C |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
2% CHG
|
6505-01-393-8432
|
Surgical Detergent |
Convatec
|
|
Quote
|
|
9412-24-12
|
6505-01-393-8432
|
Surgical Detergent |
Convatec
|
|
Quote
|
|
9412-24
|
6505-01-393-8432
|
Surgical Detergent |
Convatec
|
|
Quote
|
